HETLIOZ® (tasimelteon)
HETLIOZ (tasimelteon) is the first FDA-approved treatment for Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ (tasimelteon) is approved for nighttime sleep disturbances in Smith-Magenis Syndrome (SMS).
To read important safety information please click here.

